Stocktoria
Esperion Therapeutics, Inc. ESPR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-06-24
Esperion Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Looker Benjamin | Chief Legal Officer | 2026-06-17 | Sell | 11,824 | $3.15 |
| Koenig Sheldon L. | President and CEO | 2026-06-17 | Sell | 53,588 | $3.15 |
| Halladay Benjamin | Chief Financial Officer | 2026-06-17 | Sell | 10,773 | $3.15 |
| THOMPSON JOHN CRAIG | director | 2026-05-28 | Grant | 79,873 | — |
| Shepard Jay | director | 2026-05-28 | Grant | 79,873 | — |
| Hoffman Robert E. | director | 2026-05-28 | Grant | 79,873 | — |
| Fischer Seth H. Z. | director | 2026-05-28 | Grant | 79,873 | — |
| CARROLL J MARTIN | director | 2026-05-28 | Grant | 79,873 | — |
Source: SEC EDGAR filings · CIK 0001434868 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.